By Vin Gurrieri ( August 11, 2014, 5:28 PM EDT) -- A California federal judge on Friday refused to toss an antitrust suit by Retrophin Inc. accusing Questcor Pharmaceuticals Inc. of illegally monopolizing certain medical treatment areas through its acquisition and exclusive sales of infantile spasm drug Acthar, saying Retrophin sufficiently pled antitrust claims....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.